Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients

American Journal of Clinical Oncology: Cancer Clinical Trials - Tập 31 Số 3 - Trang 271-279 - 2008
Andrew S. Kennedy1,2, William A. Dezarn1,2, Patrick McNeillie3,4, Doug Coldwell5,6, Charles Nutting7,8,9,10, Dennis Carter8,9, Ravi Murthy11,12, Steven C. Rose1,2, Richard R.P. Warner3,4, David Liu5,6, Holger Palmedo8,9, Carroll Overton7,10, Bonita Jones7,10, Riad Salem11,12
1University of California San Diego, San Diego, CA
2Wake Radiology Oncology, Cary, NC
3Mt. Sinai Medical Center, New York, NY
4University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
5Inland Imaging, LLC. Spokane, WA
6University of Texas Southwest, Dallas, TX
7Banner Good Samaritan Medical Center, Phoenix, AZ
8Skyridge Medical Center, Denver, CO
9University Hospital of Bonn, Bonn, Germany
10Wake Radiology, Raleigh, NC
11Northwestern Medical Center, Chicago, IL
12The University of Texas MD Anderson Cancer Center, Houston, TX

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kaltsas, 2004, Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours., Eur J Endocrinol, 151, 15, 10.1530/eje.0.1510015

Oberg, 2006, Molecular imaging in diagnosis of neuroendocrine tumours., Lancet Oncol, 7, 790, 10.1016/S1470-2045(06)70874-9

Modlin, 1997, An analysis of 8305 cases of carcinoid tumors., Cancer, 79, 813, 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2

Oberg, 2003, Diagnosis and treatment of carcinoid tumors., Expert Rev Anticancer Ther, 3, 863, 10.1586/14737140.3.6.863

Akerstrom, 2005, Management of midgut carcinoids., J Surg Oncol, 89, 161, 10.1002/jso.20188

Oberg, 2002, Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment., Curr Opin Oncol, 14, 38, 10.1097/00001622-200201000-00008

Kaltsas, 2004, The diagnosis and medical management of advanced neuroendocrine tumors., Endocr Rev, 25, 458, 10.1210/er.2003-0014

Modlin, 2005, Current status of gastrointestinal carcinoids., Gastroenterology, 128, 1717, 10.1053/j.gastro.2005.03.038

Oberg, 1999, Neuroendocrine gastrointestinal tumors—a condensed overview of diagnosis and treatment., Ann Oncol, 10, S3, 10.1093/annonc/10.suppl_2.S3

Abrams, 1987, Objective response of malignant carcinoid to radiation therapy., Int J Radiat Oncol Biol Phys, 13, 869, 10.1016/0360-3016(87)90101-5

Chakravarthy, 1995, Radiation therapy in the management of patients with malignant carcinoid tumors., Cancer, 75, 1386, 10.1002/1097-0142(19950315)75:6<1386::AID-CNCR2820750622>3.0.CO;2-U

Gaitan-Gaitan, 1975, Carcinoid tumor-cure by irradiation., Int J Radiat Oncol Biol Phys, 1, 9, 10.1016/0360-3016(75)90004-8

Keane, 1981, Whole abdominal radiation in the management of metastatic gastrointestinal carcinoid tumor., Int J Radiat Oncol Biol Phys, 7, 1519, 10.1016/0360-3016(81)90081-X

Samlowski, 1986, Evaluation of the response of unresectable carcinoid tumors to radiotherapy., Int J Radiat Oncol Biol Phys, 12, 301, 10.1016/0360-3016(86)90342-1

Schupak, 1991, The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors., Int J Radiat Oncol Biol Phys, 20, 489, 10.1016/0360-3016(91)90061-8

Eriksson, 1998, Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors., Cancer, 83, 2293, 10.1002/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E

Gupta, 2005, Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival., Cancer, 104, 1590, 10.1002/cncr.21389

Moertel, 1994, The management of patients with advanced carcinoid tumors and islet cell carcinomas., Ann Intern Med, 120, 302, 10.7326/0003-4819-120-4-199402150-00008

O'Toole, 2005, Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours., Best Pract Res Clin Gastroenterol, 19, 585, 10.1016/j.bpg.2005.02.011

Osborne, 2006, Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors., Ann Surg Oncol, 13, 572, 10.1245/ASO.2006.03.071

Ruszniewski, 2000, Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors., Digestion, 62, 79, 10.1159/000051860

Kennedy, 2007, Recommendations for radioembolization of hepatic malignancies using Yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium., Int J Radiat Oncol Biol Phys, 68, 13, 10.1016/j.ijrobp.2006.11.060

Kennedy, 2006, Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience., Int J Radiat Oncol Biol Phys, 65, 412, 10.1016/j.ijrobp.2005.12.051

Lewandowski, 2007, Radioembolization with (90)y microspheres: angiographic and technical considerations., Cardiovasc Intervent Radiol, 30, 571, 10.1007/s00270-007-9064-z

Murthy, 2005, Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications., Radiographics, 25, S41, 10.1148/rg.25si055515

Salem, 2006, Radioembolization with 90-Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies, Part 1: technical and methodologic considerations., J Vasc Interv Radiol, 17, 1251, 10.1097/01.RVI.0000233785.75257.9A

Salem, 2006, Radioembolization with Yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies, Part 3: comprehensive literature review and future direction., J Vasc Interv Radiol, 17, 1571, 10.1097/01.RVI.0000236744.34720.73

Salem, 2006, Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies, Part 2: special topics., J Vasc Interv Radiol, 17, 1425, 10.1097/01.RVI.0000235779.88652.53

Ho, 1997, Clinical evaluation of the partition model for estimating radiation doses from Yttrium-90 microspheres in the treatment of hepatic cancer., Eur J Nucl Med, 24, 293

Ho, 1996, Partition model for estimating radiation doses from Yttrium-90 microspheres in treating hepatic tumours., Eur J Nucl Med, 23, 947, 10.1007/BF01084369

Kaltsas, 2005, Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues., Endocr Relat Cancer, 12, 683, 10.1677/erc.1.01116

Modlin, 1997, A 40-year analysis of 265 gastric carcinoids., Am J Gastroenterol, 92, 633

Moertel, 1973, Clinical management of advanced gastrointestinal cancer., Semin Drug Treat, 3, 55

Nolan, 1973, Regional internal radiation for hepatic cancer., Minerva Oncol, 1, 104

Norton, 2005, Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases., Best Pract Res Clin Gastroenterol, 19, 577, 10.1016/j.bpg.2005.04.003

Oberg, 1998, Carcinoid tumors: current concepts in diagnosis and treatment., Oncologist, 3, 339, 10.1634/theoncologist.3-5-339

Simon, 1968, Intra-arterial irradiation of carcinoid tumors of the liver., Am J Roentgenol Radium Ther Nucl Med, 102, 552, 10.2214/ajr.102.3.552

Veenendaal, 2006, Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy., World J Surg Oncol, 4, 35, 10.1186/1477-7819-4-35

Zuetenhorst, 1999, Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination., Eur J Gastroenterol Hepatol, 11, 1157, 10.1097/00042737-199910000-00014

Soreide, 1992, Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors., Surgery, 111, 48

Chamberlain, 2000, Hepatic neuroendocrine metastases: does intervention alter outcomes?, J Am Coll Surg, 190, 432, 10.1016/S1072-7515(00)00222-2

Hibi, 2007, Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan., Jpn J Clin Oncol, 37, 102, 10.1093/jjco/hyl140

Nave, 2001, Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years., Surgery, 129, 170, 10.1067/msy.2001.110426

Reddy, 2007, Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis., J Am Coll Surg, 204, 372, 10.1016/j.jamcollsurg.2006.12.019

Sarmiento, 2003, Hepatic surgery for metastases from neuroendocrine tumors., Surg Oncol Clin N Am, 12, 231, 10.1016/S1055-3207(02)00076-5

Brown, 1999, Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms., J Vasc Interv Radiol, 10, 397, 10.1016/S1051-0443(99)70055-2

Clouse, 1994, Hepatic arterial chemoembolization for metastatic neuroendocrine tumors., Digestion, 55, 92, 10.1159/000201208

Dominguez, 1999, Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours., Ital J Gastroenterol Hepatol, 31, S213

Drougas, 1998, Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors., Am J Surg, 175, 408, 10.1016/S0002-9610(98)00042-7

Kim, 1999, Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma., Cancer Invest, 17, 474, 10.3109/07357909909032856

Kress, 2003, Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors–a retrospective single-center analysis., Digestion, 68, 94, 10.1159/000074522

Loewe, 2003, Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results., AJR Am J Roentgenol, 180, 1379, 10.2214/ajr.180.5.1801379

Roche, 2003, Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors., Eur Radiol, 13, 136, 10.1007/s00330-002-1558-0

Therasse, 1993, Transcatheter chemoembolization of progressive carcinoid liver metastasis., Radiology, 189, 541, 10.1148/radiology.189.2.7692465

Kennedy, 2002, Hepatic artery brachytherapy for neuroendocrine carcinoma., Regul Pept, 108, 32

McStay, 2005, Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy., Radiology, 237, 718, 10.1148/radiol.2372041203

Safford, 2004, Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients., Cancer, 101, 1987, 10.1002/cncr.20592

Ruszniewski, 1993, Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients., Cancer, 71, 2624, 10.1002/1097-0142(19930415)71:8<2624::AID-CNCR2820710830>3.0.CO;2-B

Clouse, 1993, Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder., J Vasc Interv Radiol, 4, 717, 10.1016/S1051-0443(93)71956-9

Simon, 1968, Intra-arterial irradiation of carcinoid tumors of the liver., Am J Roentgenol Radium Ther Nucl Med, 102, 552, 10.2214/ajr.102.3.552

Ho, 2007, Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors., AJR Am J Roentgenol, 188, 1201, 10.2214/AJR.06.0933

Gray, 2001, Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer., Ann Oncol, 12, 1711, 10.1023/A:1013569329846

Kennedy, 2006, Fractionation, dose selection, and response of hepatic metastases of neuroendocrine tumors after 90Y microsphere brachytherapy., Brachytherapy, 5, 103

Kennedy, 2004, Pathologic response and microdosimetry of 90Y microspheres in man: review of four explanted whole livers., Int J Radiat Oncol Biol Phys, 60, 1552, 10.1016/j.ijrobp.2004.09.004

Sharma, 2007, Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy., J Clin Oncol, 25, 1099, 10.1200/JCO.2006.08.7916

Stubbs, 2001, Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases., J Gastrointest Surg, 5, 294, 10.1016/S1091-255X(01)80051-2

Stubbs, 2006, Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients., ANZ J Surg, 76, 696, 10.1111/j.1445-2197.2006.03834.x

Ho, 1998, Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review., Cancer, 83, 1894, 10.1002/(SICI)1097-0142(19981101)83:9<1894::AID-CNCR4>3.0.CO;2-O

Lau, 1998, Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres., Int J Radiat Oncol Biol Phys, 40, 583, 10.1016/S0360-3016(97)00818-3

Lau, 1994, Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study., Br J Cancer, 70, 994, 10.1038/bjc.1994.436

Kennedy, 2003, Proceedings of the 14th International Congress on Anti-Cancer Treatment., 1, 156

Steel, 2004, Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of cisplatin versus 90-yttrium microspheres (therasphere)., Psychooncology, 13, 73, 10.1002/pon.725